Abstract
The regulatory regions of 52 erm (A) [formerly erm (TR)] clinical Streptococcus pyogenes isolates were studied. Differences in the upstream regulatory region of erm (A) correlated with macrolide/lincosamide resistance patterns. Nine macrolide/lincosamide/streptogramin B-resistant isolates had changes in the leader sequence of erm (A) including base changes, insertions, or deletions. Isolates were also emm typed.

This publication has 11 references indexed in Scilit: